(KKR) KKR - Overview
Private Equity, Real Estate, Credit, Infrastructure, Growth
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.56% |
| Yield on Cost 5y | 1.89% |
| Yield CAGR 5y | 6.38% |
| Payout Consistency | 87.6% |
| Payout Ratio | 14.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 40.7% |
| Relative Tail Risk | -7.95% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.64 |
| Alpha | -54.83 |
| Character TTM | |
|---|---|
| Beta | 1.775 |
| Beta Downside | 2.115 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.39% |
| CAGR/Max DD | 0.64 |
Description: KKR KKR January 27, 2026
KKR & Co. Inc. (NYSE: KKR) is a global alternative-asset manager that operates across private equity, credit, real-estate, and infrastructure. Its investment platform spans the full capital-structure spectrum-from leveraged buyouts and growth equity to distressed credit and property-level equity-targeting a broad set of industries but with pronounced emphasis on technology (software, fintech, cybersecurity, IoT), energy & infrastructure (upstream oil & gas, renewables), and business-services assets. The firm deploys both direct investments and fund-of-funds vehicles, and it routinely pursues both control and minority stakes across the lower-middle-market to large-cap segments.
As of the most recent FY 2023 filing, KKR reported assets under management (AUM) of roughly **$558 billion**, a **9 % year-over-year increase** driven largely by strong inflows into its credit and real-estate platforms. FY 2023 revenue rose to **$9.2 billion**, with net income of **$1.6 billion**, reflecting a **15 % operating margin** despite a higher cost-of-capital environment (U.S. 10-year Treasury yields averaging 4.3 %). Private-equity fundraising in 2024 is projected to decline 12 % YoY, pressuring deal-sourcing and valuation discipline, while credit spreads have narrowed by 30 bps, favoring KKR’s opportunistic credit strategies. In the technology sector, global venture-capital funding in Q4 2025 fell 18 % YoY, suggesting a potential shift toward later-stage growth equity where KKR has a competitive edge.
For a deeper, data-driven view of KKR’s valuation dynamics and scenario analysis, you may find ValueRay’s analytical dashboard useful.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 2.35b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -0.87 > 1.0 |
| NWC/Revenue: 1100 % < 20% (prev 736.1%; Δ 363.4% < -1%) |
| CFO/TA 0.01 > 3% & CFO 5.27b > Net Income 2.35b |
| Net Debt (31.77b) to EBITDA (9.29b): 3.42 < 3 |
| Current Ratio: 4.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (954.2m) vs 12m ago 1.30% < -2% |
| Gross Margin: 19.52% > 18% (prev 0.18%; Δ 1935 % > 0.5%) |
| Asset Turnover: 4.41% > 50% (prev 6.33%; Δ -1.92% > 0%) |
| Interest Coverage Ratio: 1.72 > 6 (EBITDA TTM 9.29b / Interest Expense TTM 3.15b) |
Altman Z'' 3.26
| A: 0.46 (Total Current Assets 241.26b - Total Current Liabilities 57.39b) / Total Assets 398.48b |
| B: 0.03 (Retained Earnings 12.94b / Total Assets 398.48b) |
| C: 0.01 (EBIT TTM 5.42b / Avg Total Assets 379.57b) |
| D: 0.03 (Book Value of Equity 8.33b / Total Liabilities 323.08b) |
| Altman-Z'' Score: 3.26 = A |
Beneish M -2.99
| DSRI: 1.38 (Receivables 106.60b/105.68b, Revenue 16.72b/22.81b) |
| GMI: 0.90 (GM 19.52% / 17.58%) |
| AQI: 1.03 (AQ_t 0.39 / AQ_t-1 0.38) |
| SGI: 0.73 (Revenue 16.72b / 22.81b) |
| TATA: -0.01 (NI 2.35b - CFO 5.27b) / TA 398.48b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of KKR shares?
Over the past week, the price has changed by -6.08%, over one month by -9.77%, over three months by -3.03% and over the past year by -29.70%.
Is KKR a buy, sell or hold?
- StrongBuy: 12
- Buy: 8
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the KKR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 158.4 | 35.7% |
| Analysts Target Price | 158.4 | 35.7% |
| ValueRay Target Price | 137.5 | 17.8% |
KKR Fundamental Data Overview January 27, 2026
P/E Forward = 17.5131
P/S = 5.0467
P/B = 3.9726
P/EG = 0.4922
Revenue TTM = 16.72b USD
EBIT TTM = 5.42b USD
EBITDA TTM = 9.29b USD
Long Term Debt = 53.50b USD (from longTermDebt, last quarter)
Short Term Debt = 524.5m USD (from shortTermDebt, last quarter)
Debt = 54.45b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 31.77b USD (from netDebt column, last quarter)
Enterprise Value = 144.04b USD (112.27b + Debt 54.45b - CCE 22.68b)
Interest Coverage Ratio = 1.72 (Ebit TTM 5.42b / Interest Expense TTM 3.15b)
EV/FCF = 28.32x (Enterprise Value 144.04b / FCF TTM 5.09b)
FCF Yield = 3.53% (FCF TTM 5.09b / Enterprise Value 144.04b)
FCF Margin = 30.42% (FCF TTM 5.09b / Revenue TTM 16.72b)
Net Margin = 14.05% (Net Income TTM 2.35b / Revenue TTM 16.72b)
Gross Margin = 19.52% ((Revenue TTM 16.72b - Cost of Revenue TTM 13.46b) / Revenue TTM)
Gross Margin QoQ = 24.66% (prev 21.04%)
Tobins Q-Ratio = 0.36 (Enterprise Value 144.04b / Total Assets 398.48b)
Interest Expense / Debt = 1.46% (Interest Expense 795.0m / Debt 54.45b)
Taxrate = 16.36% (359.7m / 2.20b)
NOPAT = 4.54b (EBIT 5.42b * (1 - 16.36%))
Current Ratio = 4.20 (Total Current Assets 241.26b / Total Current Liabilities 57.39b)
Debt / Equity = 1.83 (Debt 54.45b / totalStockholderEquity, last quarter 29.75b)
Debt / EBITDA = 3.42 (Net Debt 31.77b / EBITDA 9.29b)
Debt / FCF = 6.25 (Net Debt 31.77b / FCF TTM 5.09b)
Total Stockholder Equity = 27.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.62% (Net Income 2.35b / Total Assets 398.48b)
RoE = 8.62% (Net Income TTM 2.35b / Total Stockholder Equity 27.27b)
RoCE = 6.71% (EBIT 5.42b / Capital Employed (Equity 27.27b + L.T.Debt 53.50b))
RoIC = 5.92% (NOPAT 4.54b / Invested Capital 76.58b)
WACC = 8.78% (E(112.27b)/V(166.72b) * Re(12.45%) + D(54.45b)/V(166.72b) * Rd(1.46%) * (1-Tc(0.16)))
Discount Rate = 12.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 2.29%
[DCF Debug] Terminal Value 66.74% ; FCFF base≈6.15b ; Y1≈4.04b ; Y5≈1.84b
Fair Price DCF = N/A (negative equity: EV 31.70b - Net Debt 31.77b = -66.0m; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -4.87 | EPS CAGR: -48.64% | SUE: -4.0 | # QB: 0
Revenue Correlation: 56.18 | Revenue CAGR: 8.29% | SUE: 0.69 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.48 | Chg30d=-0.028 | Revisions Net=-4 | Analysts=14
EPS next Year (2026-12-31): EPS=6.73 | Chg30d=-0.064 | Revisions Net=-8 | Growth EPS=+34.7% | Growth Revenue=+35.2%